Kevin A. Welle

Kevin A. Welle

Auto-generated profile, based on publicly available information

Kevin A. Welle

University of Rochester Mass Spectrometry Resource Laboratory, Rochester, NY, 14642, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JHJohn Hasper
John Hasper
KWKevin Welle
Kevin Welle
KSKyle Swovick
Kyle Swovick
JHJennifer Hryhorenko
Jennifer Hryhorenko
SGSina Ghaemmaghami
Sina Ghaemmaghami
ABAbigail Buchwalter
Abigail Buchwalter
LMNA mutations cause laminopathies that afflict the cardiovascular system and include Hutchinson-Gilford progeria syndrome. The origins of tissue specificity in these diseases are unclear as the lamin A/C proteins are broadly expressed. We show that LMNA transcript levels are not predictive of lamin A/C protein levels across tissues and use quantitative proteomics to discover that tissue context and disease mutation each influence lamin A/C protein’s lifetime. Lamin A/C’s lifetime is an order of magnitude longer in the aorta, heart, and fat, where laminopathy pathology is apparent, than in the liver and intestine, which are spared from the disease. Lamin A/C is especially insoluble in cardiovascular tissues, which may limit degradation and promote protein stability. Progerin is even more long lived than lamin A/C in the cardiovascular system and accumulates there over time. Progerin accumulation is associated with impaired turnover of hundreds of abundant proteins in progeroid tissues. These findings identify impaired lamin A/C protein turnover as a novel feature of laminopathy syndromes.

24 May 2024 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
MMMichael E. Meadow
Michael E. Meadow
SBSarah Broas
Sarah Broas
MHMargaret Hoare
Margaret Hoare
FAFatemeh Alimohammadi
Fatemeh Alimohammadi
KWKevin A. Welle
Kevin A. Welle
SGSina Ghaemmaghami
Sina Ghaemmaghami
Within a cell, proteins have distinct and highly variable half-lives. As a result, the molecular ages of proteins can range from seconds to years. How the age of a protein influences its environmental interactions is a largely unexplored area of biology. To investigate the age-selectivity of cellular pathways, we developed a methodology termed "proteome birthdating" that barcodes proteins based on their time of synthesis. We demonstrate that this approach provides accurate measurements of protein turnover kinetics from a single biological sample encoding multiple labeling time-points. As a first application of the birthdated proteome, we investigated the age distribution of the human ubiquitinome. Our results indicate that the vast majority of ubiquitinated proteins in a cell consist of newly synthesized proteins and that these young proteins constitute the bulk of the degradative flux through the proteasome. Rapidly ubiquitinated nascent proteins are enriched in cytosolic subunits of large protein complexes. Conversely, proteins destined for the secretory pathway and vesicular transport have older ubiquitinated populations. Our data also identify a smaller subset of older ubiquitinated cellular proteins that do not appear to be targeted to the proteasome for rapid degradation. Together, our data provide an age census of the human ubiquitinome and establish proteome birthdating as a robust methodology for investigating the protein age-selectivity of diverse cellular pathways.

14 December 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
DSDerrek Schartz
Derrek Schartz
SASajal Medha K. Akkipeddi
Sajal Medha K. Akkipeddi
RRRedi Rahmani
Redi Rahmani
NENathaniel Ellens
Nathaniel Ellens
CHClifton Houk
Clifton Houk
MBMatthew T. Bender
Matthew T. Bender
BACKGROUND AND PURPOSE: Perviousness is the differential attenuation on CT of an intracranial arterial occlusive thrombus before and after IV contrast administration. While perviousness/permeability has been shown to be related to various clinical outcomes and reflects histopathologic composition, it remains unclear whether perviousness is also associated with differences in proteomic composition. MATERIALS AND METHODS: Retrieved clots from 59 patients were evaluated with quantitative mass spectrometry. Proteomic differences between high-perviousness (≥11 HU) and low-perviousness (<11 HU) clots were investigated. Perviousness as a continuous variable was also correlated with protein abundance. Last, an ex vivo lysis assay was performed to investigate the differential susceptibility to tPA, deoxyribonuclease, and ADAMTS13 thrombolysis as a function of perviousness. RESULTS: In total, 2790 distinct proteins were identified. Thrombus perviousness was associated with distinct proteomic features, including depletion of the macrophage marker CD14 (P = .039, z = 1.176) and hemoglobin subunit ζ (P = .046, z = 1.68) in pervious clots. Additionally, proteins involved in platelet cytoskeleton remodeling (tropomyosin α-3-chain) and granule secretion/aggregation (synaptotagmin-like protein 4/FC region receptor II-a) were associated with increasing perviousness (P < .006), among numerous other proteins. Monocyte/macrophage-associated proteins (apoptosis-associated specklike protein containing a CARD/SAMHD1) were also depleted in pervious emboli (P < .002). Ex vivo lysis indicated that pervious clots were more susceptible to ADAMTS13-augmented tPA thrombolysis compared with impervious clots (P < .05), though without differences in deoxyribonuclease digestion. CONCLUSIONS: Thrombus perviousness is associated with complex proteomic features, including differential abundance of platelet-related proteins in highly permeable clots with monocyte/macrophage depletion. This association may help to explain why highly pervious thrombi were also found more susceptible to ADAMTS13-augmented thrombolysis.

21 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MHMargaret Hoare
Margaret Hoare
RTRuiyue Tan
Ruiyue Tan
KWKevin A. Welle
Kevin A. Welle
KSKyle Swovick
Kyle Swovick
JHJennifer R. Hryhorenko
Jennifer R. Hryhorenko
SGSina Ghaemmaghami
Sina Ghaemmaghami
Post-translational oxidation of methionine residues can destabilize proteins or modify their functions. Although levels of methionine oxidation can provide important information regarding the structural integrity and regulation of proteins, their quantitation is often challenging as analytical procedures in and of themselves can artifactually oxidize methionines. Here, we develop a mass spectrometry-based method called Methionine Oxidation by Blocking with Alkylation (MObBa) that quantifies methionine oxidation by selectively alkylating and blocking unoxidized methionines. Thus, alkylated methionines can be used as a stable proxy for unoxidized methionines. Using proof of concept experiments, we demonstrate that MObBa can be used to measure methionine oxidation levels within individual synthetic peptides and on proteome-wide scales. MObBa may provide a straightforward experimental strategy for mass spectrometric quantitation of methionine oxidation. Significance Statement Over time, cellular proteins can become oxidatively damaged by reactive oxygen species (ROS). A residue that is particularly prone to oxidative damage is methionine. Here, we develop and validate a methodology for detecting and quantifying levels of methionine oxidation by mass spectrometry. This approach has a number of practical advantages over methods currently available for analysis of methionine oxidation. The ability to accurately quantify methionine oxidation will provide important insights into factors that influence protein homeostasis within a cell.

24 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJohn Hasper
John Hasper
KWKevin Welle
Kevin Welle
JHJennifer Hryhorenko
Jennifer Hryhorenko
SGSina Ghaemmaghami
Sina Ghaemmaghami
ABAbigail Buchwalter
Abigail Buchwalter
The lifespans of proteins can range from minutes to years within mammalian tissues. Protein lifespan is relevant to organismal aging, as long-lived proteins can accrue damage over time. It is unclear how protein lifetime is shaped by tissue context, where both cell division and proteolytic degradation contribute to protein turnover. Here, we develop turnover and replication a nalysis by 15 N isotope labeling (TRAIL) to quantify both protein and cell lifetimes with high precision and no toxicity over a 32-day labeling period across 4 mammalian tissues. We report that cell division promotes non-selective protein turnover in proliferative tissues, while physicochemical features such as hydrophobicity, charge, and intrinsic disorder exert a significant influence on protein turnover only in non-proliferative tissues. Protein lifetimes vary non-randomly across tissues after correcting for differences in cell division rate. Multiprotein complexes such as the ribosome have highly consistent lifetimes across tissues, while mitochondria, peroxisomes, and lipid droplets have variable lifetimes. These data indicate that cell turnover, sequence-encoded features, and other environmental factors modulate protein lifespan in vivo . In the future, TRAIL can be used to explore how environment, aging, and disease affect tissue homeostasis.

7 November 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
RTRuiyue Tan
Ruiyue Tan
MHMargaret Hoare
Margaret Hoare
KWKevin A. Welle
Kevin A. Welle
KSKyle Swovick
Kyle Swovick
JHJennifer R. Hryhorenko
Jennifer R. Hryhorenko
SGSina Ghaemmaghami
Sina Ghaemmaghami
The folding of most proteins occurs during the course of their translation while their tRNA-bound C-termini are embedded in the ribosome. How the close proximity of nascent proteins to the ribosome influences their folding thermodynamics remains poorly understood. Here, we have developed a mass spectrometry-based approach for determining the stabilities of nascent polypeptide chains using methionine oxidation as a folding probe. This approach enables quantitative measurements sub-global folding stabilities of ribosome nascent chains (RNCs) within complex protein mixtures and extracts. To validate the methodology, we analyzed the folding thermodynamics of three model proteins (DHFR, CheY and DinB) in soluble and ribosome-bound states. The data indicated that the ribosome can significantly alter the stability of nascent polypeptides. Ribosome-induced stability modulations were highly variable among different folding domains and were dependent on localized charge distributions within nascent polypeptides. The results implicated electrostatic interactions between the ribosome surface and nascent polypeptides as the cause of ribosome-induced stability modulations. The study establishes a robust proteomic methodology for analyzing localized stabilities within ribosome-bound nascent polypeptides and sheds light on how the ribosome influences the thermodynamics of protein folding.